FDA plans to phase out animal testing in drugs in what it calls a ‘paradigm shift’

What's new in pharma

April 11, 2025 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

K. West/CNPRC-UC Davis STAT+ | FDA plans to phase out animal testing in drugs in what it calls a 'paradigm shift' The move comes after lawmakers sought to force the agency to update regulations that would allow alternatives to animal testing. By Ed Silverman STAT+ | Inside U.S. health agencies, workers confront chaos and questions as operations come unglued Inside a layoff-wracked HHS, fears range from existential threats to mundane matters. Says one worker: "Trying to hold things together with our bare hands." By STAT Staff STAT+ | RFK Jr. attempts to rally FDA workers to his MAHA agenda RFK Jr. told workers that tackling childhood chronic diseases should be the FDA's chief priority. By Lizzy Lawrence and Matthew Herper BIO's John Crowley on RFK Jr. and tariffs, plus calls for more federal biotech funding On The Readout LOUD podcast, STAT reporters talked with BIO's CEO about RFK Jr. and tariffs, and discussed calls for more federal funds for biotech. By Allison DeAngelis, Adam Feuerstein, and Elaine Chen STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry. By Ed Silverman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser